Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients

G. Meletis, M. Ferdoutsis, G. Patsourakis, G. Gavriilidis, A. Papadaki, N. Bachlitzanakis (Heraklion, Greece)

Source: Annual Congress 2002 - Genetics of hyperreactivity and IgE/ markers for inflammatory airways disease
Session: Genetics of hyperreactivity and IgE/ markers for inflammatory airways disease
Session type: Poster Discussion
Number: 2692
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Meletis, M. Ferdoutsis, G. Patsourakis, G. Gavriilidis, A. Papadaki, N. Bachlitzanakis (Heraklion, Greece). Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients. Eur Respir J 2002; 20: Suppl. 38, 2692

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled carbon monoxide levels during treatment of acute asthma
Source: Eur Respir J 2001; 17: 1336
Year: 2001


Exhaled carbon monoxide in childhood asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Exhaled carbon monoxide level in asthmatic and healthy children
Source: Eur Respir J 2006; 28: Suppl. 50, 259s
Year: 2006

The importance of measuriing exhaled carbon monoxide in asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 82s
Year: 2003

Exhaled carbon monoxide measurement in patients with interstitial lung diseases (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008

Exhaled carbon monoxide in lung disease
Source: Eur Respir J 2003; 21: 197
Year: 2003


Increase of exhaled carbon monoxide in subjects with non-controlled asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008

Exhaled carbon monoxide in sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 669s
Year: 2004

Exhaled carbon monoxide is decreased in interstitial lung diseases (ILD)
Source: Eur Respir J 2001; 18: Suppl. 33, 195s
Year: 2001

Exhaled carbon monoxide in healthy children
Source: Eur Respir J 2005; 26: Suppl. 49, 677s
Year: 2005

Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis
Source: Eur Respir J 2002; 20: 92-99
Year: 2002



Exhaled carbon monoxide in pulmonary sarcoidosis: clinical correlations
Source: Eur Respir J 2005; 26: Suppl. 49, 79s
Year: 2005

Bronchial blood flow is normal in COPD patients and is positevily correlated with exhaled nitric oxide and the diffusion of carbon monoxide
Source: Eur Respir J 2006; 28: Suppl. 50, 652s
Year: 2006

Methacholine-induced bronchoconstriction does not modify exhaled carbon monoxide level in asthmatic subjects
Source: Eur Respir J 2001; 18: Suppl. 33, 165s
Year: 2001

Exhaled carbon monoxide: mechanisms and clinical applications
Source: Eur Respir Monogr 2010; 49: 82-95
Year: 2010


Oxidative stress and asthma: role of exhaled carbon monoxide (CO)
Source: Eur Respir J 2001; 18: Suppl. 33, 441s
Year: 2001

Novel method of measuring exhaled nitric oxide and carbon monoxide at several exhalation flow rates in normal and asthmatic subjects
Source: Eur Respir J 2001; 18: Suppl. 33, 463s
Year: 2001

Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD
Source: Annual Congress 2012 - Tobacco dependence and respiratory disease
Year: 2012


Exhaled carbon monoxide in asthma: a prospective study
Source: Eur Respir J 2003; 22: Suppl. 45, 413s
Year: 2003

Exhaled carbon monoxide as a marker of tobacco exposure: is it possible to use the same parameters in COPD patients?
Source: Eur Respir J 2006; 28: Suppl. 50, 389s
Year: 2006